We present a 67-year-old man whose longstanding suffering from repeated episodes of anemia was resolved with a ventricular septal myectomy.
The patient successfully underwent a septal myectomy.
Obstructed patients, who fail medical therapy, are usually offered invasive treatment: surgical septal myectomy, alcohol septal ablation, or DDD pacemaker.
Key words: Hypertrophic cardiomyopathy, obstructive HCM treatment, disopyramide, septal myectomy, alcohol septal ablation, echocardiography
The most recent literature is reviewed for both septal myectomy and alcohol ablation.
The two forms of invasive therapy are septal myectomy and alcohol septal ablation.
Objective: The surgical management of left ventricular outflow tract (LVOT) obstruction secondary to hypertrophic cardiomyopathy (HCM) has classically consisted of a septal myectomy.
Durable long-term results can be achieved in all patients when the mitral valve pathology is appreciated and appropriately repaired, along with a properly located and adequately sized septal myectomy.
Specialized centers referred large numbers of patients for septal myectomy
were the focus.
Some HCM patients undergo surgical septal myectomy
to correct outflow obstruction.
Surgical septal myectomy
has been employed with considerable success for over 30 years and is the gold standard to relieve symptoms and obstruction.
It is used in patients who would otherwise require septal myectomy
or other interventions.